Raymond James Financial’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.42M Sell
191,995
-40,267
-17% -$408K ﹤0.01% 3207
2025
Q4
$2.02M Sell
232,262
-7,395
-3% -$64.2K ﹤0.01% 3269
2025
Q3
$2.25M Buy
239,657
+900
+0.4% +$8.38K ﹤0.01% 3089
2025
Q2
$2.14M Sell
238,757
-142,141
-37% -$1.13M ﹤0.01% 3032
2025
Q1
$3.32M Buy
380,898
+123,307
+48% +$1.24M ﹤0.01% 2617
2024
Q4
$2.15M Buy
+257,591
New +$1.9M ﹤0.01% 2917

Other funds holding ADTN

Raymond James Financial's ADTN Position: Q1 2026 in Review

Raymond James Financial reduced its Adtran (ADTN) stake by 17% in Q1 2026, selling an estimated $408K and leaving 191,995 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Raymond James Financial first reported a position in ADTN in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.32M in Q1 2025. 227 funds tracked by Wall St. Rank hold ADTN as of Q1 2026.

  • Raymond James Financial held 191,995 shares of Adtran worth $2.42M as of Q1 2026.
  • Raymond James Financial sold 40,267 Adtran shares in Q1 2026, an estimated $408K.
  • Adtran made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3207 holding.
  • Raymond James Financial first reported a position in Adtran in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Adtran position peaked at $3.32M in Q1 2025.
  • 227 funds tracked by Wall St. Rank held Adtran as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.